STANT: New Biotech Company at Pivot Park
STANT, a new Dutch company based at the Pivot Park in Oss, is developing proprietary inhibitors of the STING pathway with a unique and differentiated mechanism of action. The company was founded based on insights from Søren R. Paludan and Sonia Assil at Aarhus University (Denmark). It is supported by drug discovery and development veterans and serial entrepreneurs Allard Kaptein, Hans van Eenennaam, Jac Wijkmans, Lars Østergaard, and Paul Vink. The company has secured seed funding from BOM and First Fund.
More information here.
Find more news here.


